Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro
Authors:
- 27 March 2012
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 15 (3) , 250-255
Abstract
The influence of the bisphosphonate zoledronic acid (ZA) on prostate cancer (PC) growth, adhesion and invasive behavior was investigated. PC-3, DU-145 and LNCaP cells were treated with ZA, and tumor-cell growth was then investigated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Furthermore, tumor-cell adhesion to vascular endothelium or to immobilized extracellular matrix proteins, as well as migratory properties of the cells, was evaluated. Integrin β subtypes, integrin-dependent signaling, as well as cell-cycle regulating proteins, were analyzed by western blots. ZA dose-dependently reduced tumor-cell growth but did not impair tumor–endothelium and tumor–matrix interaction. However, ZA significantly inhibited tumor migration and invasive activity. Cyclin E was reduced by ZA in LNCaP and DU-145, and p21 was elevated in LNCaP cells. p27 was upregulated in all tumor cell lines, compared with the controls. ZA elevated β1-integrin in PC-3 and diminished β4-integrin in PC-3 and DU-145 cells. ZA inhibits PC growth and motility but does not influence the mechanical contact between tumor cells and the vascular wall.Keywords
This publication has 33 references indexed in Scilit:
- Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 ActivationJournal of Biological Chemistry, 2012
- XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27Kip1The Prostate, 2011
- Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarraysHuman Pathology, 2011
- Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis ModelPLOS ONE, 2011
- The α2β1 integrin is a metastasis suppressor in mouse models and human cancerJournal of Clinical Investigation, 2011
- Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancersJournal of Carcinogenesis, 2011
- Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation ProcessCancer Research, 2010
- ZEB1 Coordinately Regulates Laminin-332 and β4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells*Journal of Biological Chemistry, 2010
- RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acidThe Prostate, 2008
- Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysisProceedings of the National Academy of Sciences, 2006